Elsevier publishing – a look at the numbers, and more
Key journal performance data for 2015 and other highlights from a business that is doing a lot more than publishing
One thing we know from serving the scientific community is that researchers like data. At Elsevier we appreciate data as well, so each year we compile and validate a
wide range of figures that we feel demonstrates that we’re serving our community well. We have just reviewed and certified all the data for 2015 and are pleased to share some of the more interesting numbers. The highlight for 2015 is that, along with our editors, authors and reviewers, we increased article
volume while maintaining quality and reached new heights in readership, usage and citation.
More importantly, authors, students and customers advanced science and improved healthcare by using this world-class content along with our analytics and decision tools to make critical decisions, enhance productivity and improve outcomes.
- Authors: 1.8 million unique authors worldwide submitted 1.3 million manuscripts to Elsevier journals. (For context, we estimate the total number of active researchers globally at some 7.8 million in 2015.1)
- Reviews: 700,000 peer reviewers conducted 1.8 million article reviews, under the guidance of approximately 17,000 "high level handling editors." An additional 63,000 editors are affiliated with our journals, totaling 80,000 Elsevier editors. Approximately 7,000 of those editors were
appointed in 2015.
- Articles: Approximately 400,000 of those manuscripts were eventually published in approximately 2,500 active Journals — 73 of which were launched in 2015. 400,000 is about 16%2 of the total number of scholarly articles published worldwide in 2015.
- Archive: The 400,000 new articles brought the total number of documents available on ScienceDirect to more than 13 million. (It is over 14 million today.)
- Access: These articles were accessed by around 12 million people per month, with close to 900 million full-text article downloads for the year.
- Citations: Elsevier articles published in the 5 years ending 2014 were cited 11.5 million times in the same period,3meaning Elsevier punches above its weight with more than 25% citation share.
Each of those numbers mark historic highs. Now consider the above data related to citation impact, a commonly-used proxy for quality:
- Elsevier’s share of the top-cited 1% of all articles published in the 5 years ending 2014 was 21.1%.3 So while we publish 16% of all scholarly articles, we publish 21% of the highest quality (‘Highest’=top 1%).
- When you segment articles published in subscription-based journals by their appearance in journals classified as high, medium and low field-weighted citation impact4, we publish:
- High (representing 10% of all articles): 21% Elsevier article share
- Medium (representing 56% of all articles): 25% Elsevier article share
- Low (representing 33% of all articles): 4% Elsevier article share
Now let’s look specifically at open access articles.
- We ended 2015 as the 4th largest open access publisher, with 20,000 open access (author or funder paid) articles in 2015. That represented 36% growth over 2014, whereas the market is projected to have grown at 15%5. The largest OA market provider actually
reduced output year over year
- We launched 33 new fully open access titles in 2015, including Heliyon, our new cross-discipline Journal, bringing our total to approximately 170. Currently more than 1700 Elsevier journals offer both subscription and open access publishing options (hybrid
journals) and we publish 104 open archive journals.
- If you consider green open access options, all of our 2500 journals permit authors to share their preprints and accepted manuscripts in line with our sharing policy.
- Like subscription articles, author-paid content exceeds the market as well. On a field-weighted citation impact basis, our OA articles score 1.1, compared to the market at just 0.9.
These are impressive data, but publishing is only half of the story at Elsevier today. Over the last few decades, we curated and published content, presenting our users with material to read. Going forward, we will continue to produce that highly relevant academic and professional research and knowledge.
But we are now combining that knowledge with smart technology. This allows us to deliver the exact pieces of knowledge users need to support their decision and when they need to make it.
So in many ways, we’re more of a data company than a publishing company today. We have several maturing products and tools that help aggregate, analyze and make recommendations based on data and we increasingly work with institutions as solutions provider and partner to navigate an increasingly data
Mendeley, for example is thriving as a social collaborative network, with more than 4.6 million registered users, with 817 million full text articles in their libraries, up from 2.5 million users with approximately 300 million articles when we merged in April 2013. In November 2015, it launched the Mendeley Data repository to do more with the data from that research.
Our Clinical Solutions and Education businesses also innovated and evolved throughout 2015. The acquisition of InferMed combined
Elsevier’s extensive content with a powerful new clinical decision support engine. We also introduced Sherpath Adaptive Learning, which provides an individualized and more effective learning experience for nursing and health students. Clinical Key is growing strongly, currently
accessed by more than 3,500 institutions, and we launched a new version for nursing. ExamPrep was introduced in Europe to help schools and universities track their performance.
We embarked on a number of high-profile partnerships to strengthen our engagement with the science and health sectors, including REIsearch, which brought together researchers, citizens, industry and policy makers to address societal challenges. We also supported the Francis Crick Institute,
the Golden Goose Awards and Falling Walls. We issued a report on Sustainability research with SciDev.net,
plus numerous other reports, sponsorships and awards, with special emphasis on the developing world.
We also recently launched a new Empowering Knowledge tagline and brand campaign. Empowering Knowledge celebrates the extraordinary people Elsevier strives to serve. Like many of our customers, we’re making a lot of changes at Elsevier, small and large, many
behind the scenes, to enable a smarter user experience to advance science, technology and health. We invite you to view a series of videos that showcase the work of some of people we serve.
While it was a tremendous year for our community, I don’t mean to gloss over some ongoing relationship issues we have with some parts of the academic community. Or the technical hurdles to address from time to time. We committed back in 2012 to spend more time listening, learning and communicating
with all our communities, and while we are doing just that, there is more work to be done. Meanwhile, we remain committed to working on communicating the value we provide alongside our efforts to improve our customers’ ability to reach their objectives.
We look forward to continuing this important work in support of the research community.
1 Elsevier analysis based on data from OECD and UNESCO.
2 Elsevier’s historical article share has been reported as high as 25%, and is now 16%. This is due to a migration from using Thomson Reuter data to Scopus, which has a more inclusive data set.
3 Elsevier analysis of Scopus data (2014 is the latest year for which complete data are available).
4 Field-weighted citation impact is an indicator which accounts for field-based differences in citation practices to allow comparison of citation impact across research disciplines, and is always benchmarked to a global baseline of 1. In this analysis, ‘high’ is defined as those with a value
greater than 2, ‘medium’ less than 2 and greater than 0.5, and ‘low’ less than 0.5.
5 This is an expected, though not yet confirmed market growth number for 2015. Recent year growth rates have been 15%.
Elsevier Connect Contributor
As VP and Head of Global Corporate Relations at Elsevier, Tom Reller (@TomReller) leads a global team of media, social and web communicators for the world's largest provider of scientific, technical and medical (STM) information products and services. Together, they work to build on Elsevier's reputation by promoting the company's numerous contributions to the health and science communities, many of which are brought to life in this online community and information resource: Elsevier Connect.
comments powered by Disqus